At the intersection of healthcare and technology, medtech companies are leveraging innovative solutions to improve patient care and health outcomes. Industry leaders are well-positioned to deliver shareholder value by addressing the growing healthcare demands of an aging global population and the rising prevalence of chronic diseases. Recent breakthroughs in artificial intelligence (AI) and robotics have unlocked new growth opportunities, further supporting a robust long-term outlook. Here are two fantastic ...

For not just years but decades, Medtronic (MDT 0.04%) has proven to be a reliable dividend growth stock to own. The medical device maker has been increasing its payout regularly, and with a yield of more than 3%, it pays more than twice what the S&P 500 averages (1.3%). But these days, the stock's payout ratio is high, and investors may think twice about how safe the dividend is. A long streak, after all, is no guarantee that future payouts will be secure. Let's take a closer look at whether Medtronic's div ...

GALWAY, Ireland, Jan. 6, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare conference on Monday, January 13, 2025.Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the company beginning at 2:15 p.m. PST (4:15 p.m. CST). Immediately following the presentation, Martha will be joined by other Medtronic leaders to answer question ...

iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income , diversification , and inflation hedging . Get started with a Free Two-Week Trial and take a look at our top ideas across our exclusive income-focused portfolios.Dividend aristocrats with growing fundamentals can be great additions to an income portfolio, especially when they can be bought at a value price. Such I fin ...

The latest trading session saw Medtronic (MDT) ending at $80.95, denoting a +0.91% adjustment from its last day's close. The stock's change was less than the S&P 500's daily gain of 1.26%. Meanwhile, the Dow experienced a rise of 0.8%, and the technology-dominated Nasdaq saw an increase of 1.77%.Coming into today, shares of the medical device company had lost 4.66% in the past month. In that same time, the Medical sector lost 6.56%, while the S&P 500 lost 2.82%.The investment community will be paying close ...

Artificial intelligence (AI) has fundamentally reshaped the MedTech landscape in 2024, revolutionizing diagnostics, treatment and operational efficiency. AI-powered diagnostics have taken center stage, enhancing accuracy and speed. For instance, AI algorithms now detect anomalies in imaging studies with unprecedented precision, aiding radiologists and reducing diagnostic errors.Personalized medicine has also seen remarkable advancements, with AI analyzing genetic, lifestyle and clinical data to recommend ta ...

公司和行业分析 - 全球最大的医疗技术和解决方案提供商之一Medtronic plc (NYSE: MDT) 提供数百种创新解决方案 其产品针对心脏节律管理 脊柱和外科领域 [2] - Medtronic plc 的股票受到机构市场参与者的关注 分析师通过股票所有权 期权或其他衍生品持有该公司的长期头寸 [2]

股价表现 - Medtronic股价在最近一个交易日收于79.99美元 较前一交易日下跌0.05% [1] - 过去30天 Medtronic股价下跌5.6% 表现逊于行业5%的跌幅和标普500指数0.7%的跌幅 [2] - Medtronic股价目前低于50日和200日移动平均线 可能进一步走低 [7] 行业环境 - 2024年医疗产品行业面临挑战 红海地区地缘政治压力导致货运成本上升和交货时间延长 对Medtronic及其竞争对手如Abbott和Boston Scientific的利润率造成压力 [1] - 美联储对2025年降息的保守态度导致市场情绪整体下降 尽管全球通胀率预计将从2023年的6.8%降至2024年的5.8%和2025年的4.3% [5] - 中美贸易摩擦加剧 中国以量定价采购和"中国制造2025"计划对美国医疗设备业务产生重大影响 Medtronic约7%的运营收入来自中国 [6] 公司业务 - Medtronic在心血管领域扩大市场份额 依靠心脏节律管理和结构性心脏领域的产品发布 [10] - 高血压业务带来数十亿美元机会 美国医疗保险和医疗补助服务中心已为Symplicity Spyral肾去神经导管确定住院和门诊过渡性支付 [11] - 在MedSurg领域 Medtronic扩大Hugo RAS的生产 外科和神经科学产品组合继续做出积极贡献 起搏器业务保持强劲增长 [12] 财务指标 - Medtronic当前股息收益率为3.5% 高于行业和板块平均水平 公司当前派息率为53% 高于行业的36.5% [13] - Medtronic股票估值较低 其未来12个月市盈率为14.0倍 低于行业平均的20.34倍 [18] 长期前景 - 尽管面临行业挑战 Medtronic凭借强劲的基本面和灵活的业务战略执行 长期前景依然光明 [9] - 公司在全球范围内战略扩张 以满足对先进医疗设备的需求 创新和市场扩张努力有助于抵消通胀和供应中断的影响 [10][12]

Robotic surgery used to be fodder for science fiction movies. Not anymore. They are becoming more mainstream by the day. While fully autonomous surgeries in the medical sector are not yet a reality, the field is evolving quickly. Currently, robotics are being used to augment the surgeon’s abilities to perform more accurate, safe, and efficient surgeries. That’s why they are called robotic-assisted surgeries. Intuitive Surgical Inc. NASDAQ: ISRG has been at the forefront of robotic-assisted surgeries with it ...

The Health Care sector has taken it on the chin in the past month. President-elect Trump's win, and subsequent pick to lead the Department of Health and Human Services (HHS), was met with selling pressure in November across much of the pharma andFreelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. My passion is ...